Terumo (TRUMY) Earnings Date, Estimates & Call Transcripts → Elon’s New Device is About to Shock the World (From InvestorPlace) (Ad) Free TRUMY Stock Alerts $17.41 -0.34 (-1.92%) (As of 05/17/2024 ET) Add Compare Share Share EarningsStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort InterestStock AnalysisAnalyst ForecastsChartEarningsFinancialsHeadlinesInsider TradesSEC FilingsShort Interest Skip Charts & View Estimated and Actual Earnings DataEarnings Per ShareRevenueTRUMY Earnings Estimates and Actuals by QuarterEarnings Estimates and Acutals by Quarter Chart DescriptionThe chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.TRUMY Estimated and Actual Revenue by Quarter Estimated Revenue and Actual Revenue by Quarter Chart DescriptionThe chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter. Ad Stansberry ResearchA letter is coming from the "Bureau of the Fiscal Service".Is your bank next? A powerful new trend is spreading like wildfire inside the US financial system. At least 41 banks are already involved. But the Federal Reserve predicts that number will grow fast.See if your bank is involved right here. Terumo Analyst EPS EstimatesCurrent Year EPS Consensus Estimate:$0.57 EPSNext Year EPS Consensus Estimate: $0.67 EPS Terumo Earnings History by Quarter Custom Range 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years 5 Years Time Frame * Start Date * End Date Export to Excel DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueCall Transcript2/7/2024Q4 2023$0.1350$0.1350-$0.27-$1.62 billion11/14/2023Q2 2024-$0.13+$0.13$0.26-$1.58 billion8/9/2023Q1 2024-$0.11+$0.11$0.22-$1.57 billion5/15/2023Q4 2023-$0.10+$0.10$0.20-$1.53 billion2/9/2023Q3 2023-$0.14+$0.14$0.28-$1.52 billion11/10/2022Q2 2023-$0.0850+$0.0850$0.17-$1.49 billion Get the Latest News and Ratings for TRUMY and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Terumo and its competitors with MarketBeat's FREE daily newsletter. 8/9/2022Q1 2023-$0.1150+$0.1150$0.23-$1.52 billion5/12/2022Q4 2022-$0.0950+$0.0950$0.19-$1.55 billion2/9/2022Q3 2022-$0.1250+$0.1250$0.25-$1.57 billion11/4/2021Q2 2022-$0.1350+$0.1350$0.27-$1.57 billion8/4/2021Q1 2022-$0.17+$0.17$0.34-$1.57 billion Terumo Earnings - Frequently Asked Questions How much revenue does Terumo generate each year? Terumo (OTCMKTS:TRUMY) has a recorded annual revenue of $6.07 billion. How much profit does Terumo generate each year? Terumo (OTCMKTS:TRUMY) has a recorded net income of $661.01 million. TRUMY has generated $0.47 earnings per share over the last four quarters. What is Terumo's price-to-earnings ratio? Terumo (OTCMKTS:TRUMY) has a trailing price-to-earnings ratio of 36.65 and a forward price-to-earnings ratio of 30.54. What is Terumo's EPS forecast for next year? Terumo's earnings are expected to grow from $0.57 per share to $0.67 per share in the next year, which is a 17.54% increase. More Earnings Resources from MarketBeat Related Companies: Henry Schein Earnings Results West Pharmaceutical Services Earnings Results ICON Public Earnings Results Koninklijke Philips Earnings Results Coloplast A/S Earnings Results Zimmer Biomet Earnings Results Cardinal Health Earnings Results STERIS Earnings Results Merck KGaA Earnings Results BioNTech Earnings Results Earnings Tools: Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country: U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Australia Earnings Reports Latest Articles: Baidu Stock Earnings Prove Ray Dalio Right about China?Home Depot: Earnings Mixed, Wait to Buy the DipTraders Sell but Investors Still Win After Palantir's EarningsTech Earnings Insights: Where Opportunity Meets UncertaintyApple’s Earnings Show Investors Its Strength and Its WeaknessCarvana’s Q1 Earnings: A Profitability U-TurnPayPal’s Strong Earnings Growth and Strategic Evolution This page (OTCMKTS:TRUMY) was last updated on 5/18/2024 by MarketBeat.com Staff From Our PartnersObama’s Forever Term [exposed]Porter & CompanyThe Overlooked Retirement Asset You Probably Don’t OwnCrypto 101 MediaCEO of Biggest AI Chipmaker Just Dropped a Bombshell…Banyan Hill PublishingThe Presidential candidate you should REALLY be worried aboutStansberry ResearchMost important medical advance in 100 yearsThe Oxford ClubMake this ONE trade on Tuesday at 2 p.m. EST!Monument Traders AllianceForget Bitcoin. Crypto Millionaire Predicts 8,788% Gains For THISParadigm Press[URGENT] DO NOT Touch These AI Stocks!Weiss Ratings Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Terumo Co. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
